Gene Expression Markers for Chronic Valvular Disease Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective biomarkers for diagnosing chronic valvular disease in animals, making early detection and treatment challenging due to the absence of reliable diagnostic agents.
Innovation Solution
The method involves analyzing biological samples from animals for specific gene expression markers associated with chronic valvular disease, comparing these markers to those in control animals, and using the comparison to diagnose the disease by determining differential expression levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional diagnostic methods are used, then the diagnostic process is simple, but the accuracy and reliability of diagnosis is insufficient due to lack of effective biomarkers
Solution Approach 1:
The patent introduces gene expression markers as intermediary substances that mediate between the disease state and the diagnostic measurement. These markers serve as reliable indicators that bridge the gap between the biological disease process and detectable diagnostic signals, thereby improving diagnostic accuracy without requiring direct observation of complex disease mechanisms
Solution Approach 2:
The patent replaces conventional mechanical or physical diagnostic methods with molecular biology-based detection methods. Instead of relying on physical examinations or simple laboratory tests, the invention uses gene expression analysis through techniques such as RT-PCR, microarrays, or RNA sequencing to detect disease-specific molecular signatures, thereby achieving higher precision
2Loss of time
If early detection is pursued, then treatment timing is improved, but detection difficulty increases due to absence of symptoms and reliable diagnostic agents
Solution Approach 1:
The patent enables preliminary detection of chronic valvular disease by identifying gene expression marker profiles before clinical symptoms manifest. By monitoring these molecular markers in asymptomatic animals, the system allows for early intervention and treatment planning, preventing disease progression to later stages with more severe symptoms
Solution Approach 2:
The patent establishes a feedback mechanism through continuous or periodic monitoring of gene expression markers. This allows for dynamic assessment of disease status and response to treatment, enabling及时调整 of therapeutic strategies based on molecular biomarker changes rather than waiting for clinical symptom changes
Data Source
AI summary
The invention provides methods for diagnosing chronic valvular disease in an animal. The methods comprise obtaining a sample from the animal; analyzing the sample for the presence of one or more gene expression markers associated with chronic valvular disease; comparing the amount of gene expression markers identified in the sample to a corresponding amount of the same gene expression markers present in a sample from one or more comparable control animals that do not suffer from chronic valvular disease; and using said comparison to diagnose chronic valvular disease in the animal if the gene expression markers found in the animal's sample is differentially expressed in the control animal's sample.